Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’”

• Kim Rand,
• Juan Manuel Ramos-Goñi,
• Bülent Akmaz,
• Laia Solé-Feu,
• José-Carlos Armario-Hita

Affiliations

Kim Rand

Maths in Health B.V.

Juan Manuel Ramos-Goñi

Maths in Health B.V.

Bülent Akmaz

Global Market Access, Pricing and Medical Affairs

Laia Solé-Feu

Global Market Access, Pricing and Medical Affairs

José-Carlos Armario-Hita

Department of Dermatology, University Hospital of Puerto Real, University of Cadiz